跳至主要内容
临床试验/JPRN-jRCTs011180010
JPRN-jRCTs011180010招募中2 期

Safety and efficacy of tick-borne encephalitis vaccine - TBEV2018

agasaka Atsushi0 个研究点目标入组 300 人开始时间: 2019年3月8日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 1age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Age above 1 at study consent
  • 2. Anyone who has risk of tick bite
  • 3. Subjects who understand and agree with participation of their free will

排除标准

  • 1. Patients suspected with acute illness such as fever
  • 2. Patients currently under treatment for any acute illness or patients who have not recovered from acute illness for more than 1 week
  • 3. Severe immunodeficiency
  • 4. History of severe adverse reaction or allergy after tick-borne encephalitis vaccine
  • 5. Hypersensitivity to formaldehyde, neomycin, gentamycin, protamine sulfate)
  • 6. Severe hypersensitivity to egg and chick proteins (anaphylactic reaction after oral ingestion of egg protein)
  • 7. Severe hypersensitivity to latex (anaphylactic reaction to latex)
  • 8. Pregnancy or breastfeeding
  • 9. Participants who deemed inappropriate by principal investigator
  • 10. For first time vaccination: tick bite within 4 weeks

研究者

发起方
agasaka Atsushi

相似试验

Safety and efficacy of tick-borne encephalitis... | 临床试验